Angiotensin II differentially modulates cyclooxygenase-2, microsomal prostaglandin E2 synthase-1 and prostaglandin I2 synthase expression in adventitial fibroblasts exposed to inflammatory stimuli

Journal of Hypertension

Volumn 29, Issue 3, 2011, Pages 529-536

  Galán, María ^a   Miguel, Marta ^a   Beltrán, Amada E ^a   Rodríguez, Cristina ^b   García Redondo, Ana B ^a   Rodríguez Calvo, Ricardo ^b   Alonso, María J ^c   Martínez González, José ^b   Salaices, Mercedes ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

angiotensin; COX 2; inflammation; mPGES 1; PGE2; PGI2; PGIS

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RAT; RNA STABILITY; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79951681715     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328342b271     Document Type: Article

References (37)

1. Hernanz R, Briones AM, Alonso MJ, Vila E, Salaices M. Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries. Am J Physiol Heart Circ Physiol 2004; 287:H225-H234. (Pubitemid 38802357)
2. Briones AM, Salaices M, Vila E. Ageing alters the production of nitric oxide and prostanoids after IL-1b exposure in mesenteric resistance arteries. Mech Ageing Dev 2005; 126:710-721. (Pubitemid 40693295)
3. Adeagbo AS, Zhang X, Patel D, Joshua IG, Wang Y, Sun X, et al. Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension. J Hypertens 2005; 23:1025-1036. (Pubitemid 40637922)
4. Álvarez Y, Briones AM, Balfagón G, Alonso MJ, Salaices M. Hypertension increases the participation of vasoconstrictor prostanoids from cyclo-oxygenase-2 in phenylephrine responses. J Hypertens 2005; 23:767-777. (Pubitemid 40523275)
5. Antman EM, DeMets D, Loscalzo J. Cyclooxygenase inhibition and cardiovascular risk. Circulation 2005; 112:759-767.
6. Martínez-González J, Badimón L. Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks. Curr Pharm Des 2007;13:2215-2227. (Pubitemid 47321572)
7. Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic target. Pharmacol Rev 2007; 59:207-224. (Pubitemid 47481434)
8. 2 biosynthesis in vascular smooth muscle cells. J Thromb Haemost 2007; 5:1411-1419. (Pubitemid 46969879)
9. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 2008; 29: 367-374.
10. Rebsamen MC, Capoccia R, Vallotton MB, Lang U.Roleof cyclooxygenase 2, p38 and p42/44 MAPK in the secretion of prostacyclin induced by epidermal growth factor, endothelin-1 and angiotensin II in rat ventricular cardiomyocytes. J Mol Cell Cardiol 2003; 35:81-89. (Pubitemid 36286970)
11. Ohnaka K, Numaguchi K, Yamakawa T, Inagami T. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells. Hypertension 2000; 35:68-75. (Pubitemid 30054239)
12. Alvarez Y, Pérez-Girón JV, Hernanz R, Briones AM, García-Redondo A, Beltran A, et al. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther 2007; 321:381-388. (Pubitemid 46456962)
13. Beltrán AE, Briones AM, García-Redondo AB, Rodríguez C, Miguel M, Alvarez Y, et al. p38 MAPK contributes to angiotensin II-induced COX-2 expression in aortic fibroblasts from normotensive and hypertensive rats. J Hypertens 2009; 27:142-154.
14. Soler M, Camacho M, Escudero JR, Iñiguez MA, Vila L. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ Res 2000; 87:504-507.
15. 2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress. Hypertension 2008; 52:952-959.
16. Wang M, Lee E, Song W, Ricciotti E, Rader DJ, Lawson JA, et al. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation 2008; 117:11302-11309.
17. Pham H, Chong B, Vincenti R, Slice LW. Ang II and EGF synergistically induce COX-2 expression via CREB in intestinal epithelial cells. J Cell Physiol 2008; 214:96-109. (Pubitemid 350220063)
18. Doller A, Akool EL-S, Huwiler A, Müller R, Radeke HH, Pfeilschifter J, Eberhardt W. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cd elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol Cell Biol 2008; 28:2608-2625. (Pubitemid 351542362)
19. Matsuzuka T, Miller K, Pickel L, Doi C, Ayuzawa R, Tamura M. The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines. Mol Cell Biochem 2009; 320:163-171.
20. Slice LW, Chiu T, Rozengurt E. Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways. J Biol Chem 2005; 280:1582-1593.
21. Jiang B, Xu S, Hou X, Pimentel DR, Cohen RA. Angiotensin II differentially regulates interleukin-1-b-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. J Biol Chem 2004; 279:20363-20368. (Pubitemid 38623482)
22. Peng T, Lu X, Feng Q. NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes. FASEB J 2005; 19:293-295. (Pubitemid 40189286)
23. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999; 96:7220-7225. (Pubitemid 29299642)
24. Schneider A, Zhang Y, Zhang M, Lu WJ, Rao R, Fan X, et al. Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney. Kidney Int 2004; 65:1205-1213. (Pubitemid 38406958)
25. Numaguchi Y, Harada M, Osanai H, Hayashi K, Toki Y, Okumura K, et al. Altered gene expression of prostacyclin synthase and prostacyclin receptor in the thoracic aorta of spontaneously hypertensive rats. Cardiovasc Res 1999; 41:682-688. (Pubitemid 29130632)
26. CathcartMC, Reynolds JV, O'Byrne KJ, Pidgeon GP.The roleofprostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer. Biochim Biophys Acta 2010; 1805:153-166.
27. Caughey GE, Cleland LG, Gamble JR, James MJ. Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. Role of thromboxane A2. J Biol Chem 2001; 276:37839-37845.
28. Gurgul-Convey E, Lenzen S. Protection against cytokine toxicity through endoplasmic reticulum and mitochondrial stress prevention by prostacyclin synthase overexpression in insulin-producing cells. J Biol Chem 2010; 285:11121-11128.
29. Soler M, Camacho M, Molins-Pujol AM, Vila L. Effect of an imidazolineoxyl N-oxide on prostaglandin synthesis in experimental shock: possible role of nitrogen dioxide in prostacyclin-synthase inactivation. J Infect Dis 2001; 183:105-112. (Pubitemid 32043047)
30. Ji G, Liu D, Liu J, Gao H, Yuan X, Shen G. p38 mitogen-activated protein kinase up-regulates NF-kB transcriptional activation through RelA phosphorylation during stretch-induced myogenesis. Biochem Biophys Res Commun 2010; 391:547-551.
31. Dieckgraefe BK, Weems DM. Epithelial injury induces egr-1 and fos expression by a pathway involving protein kinase C and ERK. Am J Physiol 1999; 276:G322-G330. (Pubitemid 29104145)
32. Sakaue M, Adachi H, Dawson M, Jetten AM. Induction of Egr-1 expression by the retinoid AHPN in human lung carcinoma cells is dependent on activated ERK1/2. Cell Death Differ 2001; 8:411-424. (Pubitemid 32409612)
33. Masuko-Hongo K, Berenbaum F, Humbert L, Salvat C, Goldring MB, Thirion S. Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. Arthritis Rheum 2004; 50:2829-2838. (Pubitemid 39209520)
34. Wu KK. Differential cyclooxygenase-2 transcriptional control in proliferating versus quiescent fibroblasts. Prostaglandins Other Lipid Mediat 2007; 83:175-181. (Pubitemid 46671581)
35. Doller A, Pfeilschifter J, Eberhardt W. Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell Signal 2008; 20:2165-2173.
36. Subbaramaiah K, Marmo TP, Dixon DA, Dannenberg AJ. Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. J Biol Chem 2003; 278:37637-37647. (Pubitemid 37175287)
37. 2 synthase expression. J Biol Chem 2002; 277:16355-16364. (Pubitemid 34967644)